Rigvir®, the world’s first and only non-genetically modified cancer virotherapy agent, is a non-replicative live virus; it is non-pathogenic, and does not reproduce inside the human body or transmit to others. Once introduced in the body, Rigvir® selectively seeks out cancer cells to replicate within, effectively killing the cell in the process.
While virotherapy is only now emerging as a new wave of oncological therapies, Rigvir® has been intensely studied by researchers for over 50 years, passing all phases of clinical trials, and is registered by the International Virotherapy Center in Latvia as a prescription anti-cancer drug. Though registered as a drug, Rigvir offers a completely safe clinical profile, high therapeutic index, absence of side effects, and ability to selectively target cancer cells – making it unlike most available therapeutic agents.
Hope4Cancer is the only accredited institute by the International Virotherapy Center, and the first clinic to be authorized to treat patients with Rigvir® in Mexico. With over three years of experience, we have established leadership in the administration of this therapy in conjunction with our whole-body therapeutic program, based on the Seven Key Principles of Cancer Therapy.
Clinical and preclinical studies conducted in Latvia have shown Rigvir® to be effective against a variety of cancers including:
- Breast cancer
- Liver cancer
- Lung cancer
- Colorectal cancer
- Pancreatic cancer
- Prostate cancer
- Bladder cancer
- Uterine cancer
- Kidney cancer
- Stomach cancer
However, given its universal mode of action, it is likely that Rigvir® is effective against a much larger range of cancers that have not been fully studied yet. In fact, at Hope4Cancer, we have used Rigvir® effectively against many cancers not listed here.
It is important to note that since Rigvir® is a defined pharmaceutical entity that has been established through a process of validated studies to qualify as a drug, it does not completely fall into the category of conventional, alternative, or integrative medicine. Instead, Rigvir® represents a completely new paradigm in cancer treatment, and we at Hope4Cancer are proud to offer it to our patients.